EUVIMEDObjevte EUVIMED
Crossref

Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation

Aihong Yang, Xiaoyue Yi, Hongwei Zhang, Rui Shen, Xiaodi Kou

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14529 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Aihong Yang and 4 co-authors. Institution: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Major MEDLINE topics: Cholinesterase Inhibitors, Acetylcholinesterase, Butyrylcholinesterase, Alzheimer Disease. Cited 6 times so far (Crossref); 41 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

With the increasing aging population, rational design of drugs for Alzheimer's disease (AD) treatment has become an important research area. Based on the multifunctional design strategy, four diosmetin derivatives ( 1 – 4 ) were designed, synthesized, and characterized by 1 H NMR, 13 C NMR, and MS. Docking study was firstly applied to substantiate the design strategies and then the biological activities including cholinesterase inhibition, metal chelation, antioxidation and β‐amyloid (Aβ) aggregation inhibition in vitro were evaluated. The results showed that 1–4 had good acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition, metal chelation (selective chelation of Cu 2+ ions), antioxidation, self‐induced, Cu 2+ ‐induced, and AChE‐induced Aβ aggregation inhibition activities, and suitable blood–brain barrier (BBB) permeability. Especially, compound 3 had the strongest inhibitory effect on AChE (10 −8 M magnitude) and BuChE (10 −7 M magnitude) and showed the best inhibition on AChE‐induced Aβ aggregation with 66.14% inhibition ratio. Furthermore, compound 3 could also reduce intracellular reactive oxygen species (ROS) levels in Caenorhabditis elegans and had lower cytotoxicity. In summary, 3 might be considered as a potential multifunctional anti‐AD ligand.

Subjects

MeSH terms (MEDLINE)

Cholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseAlzheimer DiseaseAmyloid beta-PeptidesDrug DesignCaenorhabditis elegansMolecular Docking SimulationBlood-Brain BarrierReactive Oxygen SpeciesFlavonoidsAnimalsLigandsHumansAntioxidantsStructure-Activity RelationshipProtein Aggregates

Author keywords

Alzheimer's diseasediosmetin derivativesmetal dyshomeostasismultifunctional ligand strategy

Substances

Cholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesteraseAmyloid beta-PeptidesLigandsReactive Oxygen SpeciesdiosmetinFlavonoidsAntioxidantsProtein Aggregates

Authors and institutions

  • School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Cite

APA

Yang, A., Yi, X., Zhang, H., Shen, R., & Kou, X. (2024). Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14529

Vancouver

Yang A, Yi X, Zhang H, Shen R, Kou X. Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14529

BibTeX
@article{Yang2024,
  author = {Yang, Aihong and Yi, Xiaoyue and Zhang, Hongwei and Shen, Rui and Kou, Xiaodi},
  title = {Diosmetin derivatives as multifunctional anti‐AD ligands: Design, synthesis, and biological evaluation},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14529}
}
Start for free →